Vitrolife

VITR.ST Large Cap

Healthcare · Medical Devices

Updated: Apr 5, 2026, 17:43 UTC

$92.75

-3.59% today

52W: $84.60 – $179.00

52W Low: $84.60 Position: 8.6% 52W High: $179.00

🔗 Compare Brokers

Key Metrics

P/E Ratio

—

Price-to-Earnings

Forward P/E

19.28x

Forward Price/Earnings

P/S Ratio

3.65x

Price-to-Sales

EV/EBITDA

14.18x

Enterprise Value/EBITDA

Div. Yield

119%

Annual dividend yield

Market Cap

$12.6B

Market Capitalization

Revenue Growth

-7%

YoY Revenue Growth

Profit Margin

-145.7%

Net profit margin

ROE

-46.54%

Return on Equity

Beta

1.76

Market sensitivity

Short Interest

—

% of float sold short

Avg. Volume

301,279

Average daily volume

Valuation Analysis

Signal

N/A

vs. S&P 500 avg P/E (24.7x)

Analyst Consensus

Strong Buy

5 analysts

Avg. Price Target

$163.40

+76.17% upside

Target Range

$110.00 – $215.00

About the Company

Vitrolife AB (publ) provides assisted reproduction products in Europe, the Middle East, Africa, Asia-Pacific, and the Americas. It offers sperm processing, oocyte retrieval needles, micromanipulation pipettes, time-lapse systems, and evaluation tools, laser and imaging systems, IVF media and oil, embryo transfer, cryopreservation, and genomics kits. The company also provides eWitness and Labware products, such as dishes, pipettes, tubes, and VitroTemp. The company was incorporated in 1989 and is based in Gothenburg, Sweden.

Sector: Healthcare Industry: Medical Devices Country: Sweden Employees: 1,151 Exchange: STO